在亚裔美国老年人中剖析阿尔茨海默病风险:分类和回归树方法
Sung Seek Moon1, Lindsey Anderson1, Jinyu Liu1
1Diana R. Garland School of Social Work, Baylor University, Waco, TX, USA.
Journal of Alzheimer's disease reports
|March 29, 2024
概括
这项研究确定了诸如独立,年龄,呼吸暂停和抗抑郁药的使用等关键因素,这些因素与亚裔美国老年人患阿尔茨海默病 (AD) 的风险有关. 这些发现有助于为这一群体制定有针对性的干预措施.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 阿尔茨海默病 (AD) 是一个重大的公共卫生问题,随着全球人口老龄化而升级.
- 现有的关于AD,社会人口统计和心血管风险的研究忽视了亚裔美国老年人群.
- 在亚裔美国老年人的特定背景下,关于AD风险因素的知识差距存在.
研究的目的:
- 研究亚裔美国老年人中社会人口因素,心血管风险,睡眠,抗抑郁药物使用和AD之间的复杂关系.
- 解决亚裔美国老年人在阿尔茨海默病研究中的不足.
- 使用分类和回归树 (CART) 方法进行详细分析.
主要方法:
- 来自2017年统一数据集 (国家阿尔茨海默氏症协调中心) 的数据分析.
- 专注于4343名亚裔美国长老的样本.
- 应用分类和回归树 (CART) 方法的应用.
主要成果:
- 卡特分析显示,阿尔茨海默病风险与包括独立程度,年龄值 (73.5岁和84.5岁),呼吸暂停,先前使用抗抑郁药物和体重指数在内的因素之间存在显著的关联.
- 在研究的人口统计学中确定了阿尔茨海默病的特定预测因素.
- 强调了临床和人口统计学变量在AD风险评估中的重要性.
结论:
- 研究结果强调需要进一步研究亚裔美国人老年人对阿尔茨海默病的性别,文化,社会人口和心血管影响.
- 结果可以指导文化敏感干预和政策的发展.
- 建议制定明智的策略,以改善社区内的医疗保健和AD管理.
相关概念视频
01:26Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
01:22Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
01:19Survival Tree
84
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
84